Loading the section…
The price of Pyxis Oncology, Inc. (PYXS) on October 9, 2026 is 2.03 USD, +2.01% on the day. Over 52 weeks the stock traded between 1.03 USD and 5.55 USD; the price now sits 22% of the way up that range. Over the past year the price changed by -30.24%. Market capitalization is 127.55 million USD, rank 206 among 372 stocks of the same industry with a known capitalization.
Closing prices for 9 October 2026
Next earnings report: 2 November 2026 · Earnings calendar
Change over the period shown (line colour): −41.16 %
Pyxis Oncology, Inc. trades on Nasdaq under the ticker PYXS. The company belongs to the Health care sector. The trading history on this page starts on 8 October 2021.
Over the past 52 weeks PYXS has traded between 1.03 $ and 5.55 $. As of 9 October 2026 the price stood 22.12 % of the way from the 52-week low to the high.
Over one year PYXS shares fell 30.24 %; over six months they rose 19.41 %. Volatility over 90 days is 124.29 %. Dividends are not included: this is price change only, as of 9 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 9.2, above the sector median of 4.0. Price to book is 4.1, above the sector median of 2.5. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 9 October 2026 | 1.99 | 2.06 | 1.98 | 2.03 | 950,400 |
| 8 October 2026 | 2.03 | 2.03 | 1.90 | 1.99 | 1M |
| 7 October 2026 | 2.02 | 2.09 | 2.00 | 2.01 | 957,800 |
| 6 October 2026 | 2.22 | 2.22 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Address:321 HARRISON AVENUE, BOSTON, MA, 02118, US
Pyxis Oncology, Inc. reported revenue of 14M $ and a net loss of 82M $ over the last four quarters. Revenue changed by −14.17 % year over year. Earnings per share are −1.30 $. Market capitalisation is 128M $.
PYXS has a return on equity of −261.40 %, below the sector median of −41.68 %. Return on assets is −127.12 %, below the sector median of −32.11 %.
| 1.2B |
| PFEPfizer, Inc. | 28.28 | +1.65 % | 922M |
| ABTAbbott Laboratories | 99.60 | +1.13 % | 921M |
| BMYBristol-Myers Squibb Company | 59.12 | −0.77 % | 714M |
| REGNRegeneron Pharmaceuticals, Inc. | 746.54 | +0.94 % | 555M |
| 2.00 |
| 2.02 |
| 1M |
| 5 October 2026 | 2.12 | 2.26 | 2.05 | 2.24 | 2M |
| 2 October 2026 | 2.21 | 2.31 | 2.10 | 2.14 | 2M |
| 1 October 2026 | 2.31 | 2.31 | 2.19 | 2.19 | 3M |
| 30 September 2026 | 2.38 | 2.41 | 2.12 | 2.33 | 8M |
| 29 September 2026 | 2.94 | 2.94 | 2.83 | 2.90 | 335,500 |
| 28 September 2026 | 2.81 | 2.91 | 2.75 | 2.90 | 368,100 |
| 25 September 2026 | 2.91 | 2.92 | 2.79 | 2.86 | 609,700 |
| 24 September 2026 | 3.22 | 3.25 | 2.86 | 2.92 | 875,300 |
| 23 September 2026 | 3.36 | 3.36 | 3.20 | 3.22 | 433,600 |
| 22 September 2026 | 3.21 | 3.41 | 3.19 | 3.36 | 479,800 |
| 21 September 2026 | 3.38 | 3.38 | 3.19 | 3.19 | 632,800 |
| 18 September 2026 | 3.38 | 3.44 | 3.33 | 3.33 | 563,900 |
| 17 September 2026 | 3.43 | 3.47 | 3.34 | 3.41 | 476,700 |
| 16 September 2026 | 3.34 | 3.42 | 3.32 | 3.34 | 639,900 |
| 15 September 2026 | 3.40 | 3.42 | 3.24 | 3.33 | 489,600 |
| 14 September 2026 | 3.21 | 3.52 | 3.21 | 3.43 | 699,500 |